COR · Cencora, Inc.
$286.132026-07-21Sector: Healthcare; Industry: Medical - Distribution; Sub-Industry: Health Care Distributors
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$298
+4.3% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($221 · $378) Analysts Range ($331 · $440) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q2 | $262.2B | — | 0.9% | 19.7% | $2.0B | $1.3B | $3.2B | 6.7% | — | 47.8% | $4.1B | $8.93 | — |
| 2025.Q1 | $294.0B | 12.1% | 1.0% | 23.4% | $2.3B | −$4.5B | −$2.2B | 7.8% | — | 50.8% | $5.0B | $7.72 | — |
| 2025.Q2 | $294.0B | 0.0% | 1.0% | 25.9% | $2.3B | −$1.2B | $1.0B | 7.0% | — | 38.2% | $6.8B | $7.72 | — |
| 2026.Q1 | $321.3B | 9.3% | 1.1% | 30.1% | $2.5B | $227MM | $2.8B | 7.3% | — | 34.5% | $8.0B | $7.95 | — |
| 2026.Q2 | $328.7B | 2.3% | 1.3% | 27.2% | $3.1B | −$6.2B | −$3.1B | 6.8% | — | 28.4% | $13.5B | $13.04 | 13.3 |
| italics below = DCF projection · 10yr Rev CAGR: 5.3% |
| 2027.Q2 | $347.6B | +5.8% | 1.1% | 26.5% | $2.9B | −$3.0B | −$128MM | 6.9% | −$120MM | 19.3% | $16.6B | $14.86 | 19.3 |
| 2028.Q2 | $368.1B | +5.9% | 1.2% | 25.8% | $3.3B | −$1.7B | $1.6B | 7.1% | $1.4B | 18.9% | $18.3B | $16.84 | 17.0 |
| 2029.Q2 | $391.3B | +6.3% | 1.3% | 25.1% | $3.7B | −$1.3B | $2.5B | 7.2% | $2.0B | 19.8% | $19.5B | $19.16 | 14.9 |
| 2030.Q2 | $414.9B | +6.0% | 1.5% | 24.3% | $4.7B | −$1.1B | $3.6B | 7.4% | $2.7B | 23.5% | $20.6B | $24.16 | 11.8 |
| 2031.Q2 | $438.5B | +5.7% | 1.5% | 23.6% | $5.0B | −$958MM | $4.1B | 7.6% | $2.9B | 23.9% | $21.6B | $25.78 | 11.1 |
|
| Term. Yr+ | $575.2B | 4.1% | 1.2% | 20.0% | $5.4B | −$1.0B | $4.4B | 8.6% | $46.5B | 22.0% | — | — | — |
Active scenario IV: $298 (+4.3% vs market)